New Hampshire’s medical marijuana program has more than doubled in size since 2016. About 4,700 patients were enrolled in the program by the end of 2017.
Michael Holt is the Therapeutic Cannabis Program Administrator for the Department of Health and Human Services. He joins us now to talk about how the state’s medical marijuana program has grown.
(Editor’s note: this transcript has been edited lightly for broadcast.)
I know that all of the data you have, of course, of patients there’s confidentiality to think about here. But what do we know, or what can we call publicly from that data?
We are tracking the qualifying medical conditions that all our patients have. Those qualifying conditions are established by the legislature. They range from epilepsy, to chronic pain, to HIV/AIDS, cancer, etc. The population base has a range of qualifying conditions.
And you’ve got people as young, as the report says, as five, but you have patients up to the age of 99. Can you tell us what the data suggests? Do you have more of one particular age group or another, or one bigger group of particular ailments that stand out?
Certainly, the vast majority of our patients are in the age range that you would typically think of as having these qualifying conditions. They’re in the 40, 50, 60-year-old age range. The number of minor patients is very low—eight as of last June, I believe 11 as of current data.
So most are middle-aged to senior citizens?
Most of that data was compiled for the state report before New Hampshire expanded its program to include more conditions like PTSD and moderate to severe chronic pain. Do you have any insight into how the change has